BackHeXun Biosciences , Ltd. Overview

HeXun Biosciences , Ltd. Receivables

Latest receivables for 6986.TWO: $93M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$93.29M
↓ 9.83% YoYΔ $-10.17M vs prior year quarter

Peer trimmed avg / median

Loading

HeXun Biosciences , Ltd. Receivables History

Loading

HeXun Biosciences , Ltd. vs. peers: Receivables Comparison

Loading

HeXun Biosciences , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

HeXun Biosciences , Ltd. (6986.TWO) FAQ

HeXun Biosciences , Ltd. (6986.TWO) currently reports a receivables of $93M as of June 2026. That compares with $100M in the prior-year period — down 9.8% year over year. Use the charts on this page to explore HeXun Biosciences , Ltd.'s receivables history and peer comparisons.

HeXun Biosciences , Ltd.'s receivables decreased from $100M to $93M — a 9.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HeXun Biosciences , Ltd. reported $93M in receivables as of June 2026. That compares with $100M in the prior-year period — down 9.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HeXun Biosciences , Ltd., and consider following 6986.TWO for alerts when major investors trade the stock.

HeXun Biosciences , Ltd. is classified in the Healthcare sector. On receivables, it currently shows $93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6986.TWO with unrelated industries.